|
Real-time Estimate
Cboe BZX
02:17:29 01/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 200.40 USD | +0.69% |
|
-3.14% | +8.93% |
| 12:22am | Axsome Therapeutics Initiates SUMMIT Phase 3 Trial Of AXS-05 In Smoking Cessation | CI |
| 09:36pm | Axsome Therapeutics Starts Phase 3 Trial of AXS-05 for Smoking Cessation | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- AXSM Stock
- Consensus Axsome Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
